Three Continents
Independently Discovered
This Backyard Weed for Skin.
Acalypha indica — the Indian copperleaf that Asia, Africa, and South America all documented for the same applications — and the safety consideration that most discussions omit
Kucing galak (Acalypha indica) grows in backyards, roadsides, and disturbed ground across tropical Malaysia. It is classified as a weed. It is also found in traditional medicine across India, Sri Lanka, China, the Philippines, West Africa, the Caribbean, and South America — populations that had no contact with each other — all documenting it for the same applications: skin conditions, respiratory infections, wound healing, and antimicrobial use. Three continents. Same plant. Same observations. This article covers what the research found, and includes a safety note on the cyanogenic compound that most discussions of kucing galak do not mention.
Acalypha indica contains cyanogenic glycosides — compounds that can release hydrogen cyanide under certain conditions. At the concentrations present in the plant used in traditional preparations, this does not represent a toxicity risk for external (topical) use or for the small amounts used in traditional culinary contexts across Asia and Africa.
For internal use: traditional preparations typically use small quantities of leaves as a vegetable or in decoction at moderate doses. Large-quantity internal consumption of raw leaves is not recommended. The traditional pattern of use — leaves as a vegetable in cooked preparations, or as a moderate-dose decoction — has not produced documented mass poisoning events. However, this requires acknowledgment in any responsible discussion of the plant.
The primary and most evidence-supported applications are topical — wound healing, skin conditions, and antimicrobial applications. The safety profile for topical use is well-documented and favourable.
What the Evidence Shows
Asia (India, Malaysia, Sri Lanka, Philippines, China), Africa (West Africa, Madagascar), and South America (Caribbean, Brazil) all independently documented Acalypha indica for skin conditions, wound healing, and respiratory applications. Independent empirical convergence across populations with no historical contact.
Acalypha indica extracts demonstrate documented antimicrobial activity against Candida albicans, Aspergillus niger, and E. coli, with root, leaf, and stem extracts showing potency comparable to standard antifungal reference compounds in multiple studies. The antifungal activity explains the traditional skin and wound applications — Candida and Aspergillus are common causes of skin and wound infections in tropical climates.
Phytol, a diterpene compound in Acalypha indica, suppresses pro-inflammatory cytokines through documented NF-kB pathway downregulation — the same mechanism documented across multiple AJHerbs articles. Multiple studies confirm significant anti-inflammatory activity in carrageenan-induced inflammation models.
Leaf juice at small doses demonstrates documented expectorant and bronchial smooth muscle effects. Used traditionally for bronchitis, asthma, and respiratory congestion across multiple Asian traditional medicine systems. The mechanism aligns with volatile oil compounds affecting bronchial mucosa.
The most consistently documented traditional use across all three continents is topical application for scabies and cutaneous (skin) infections. The antimicrobial activity against the most common pathogens in skin conditions provides the mechanistic basis for this convergent traditional observation.
Acalypha indica belongs to the Euphorbiaceae family — the same family as cassava, rubber tree, and castor oil plant. Multiple Euphorbiaceae species contain cyanogenic glycosides or other secondary metabolites that require appropriate preparation for safe use. This family context is relevant for the safety consideration acknowledged in this article.
Five Things That Reframe Kucing Galak
The most remarkable pharmacological fact about Acalypha indica is not any single compound. It is the convergent independent observation of the same applications across three continents by populations that had no contact.
India documented kucing galak (kuppaimeni) for skin conditions, wound healing, respiratory infections, and as an expectorant. West African traditional medicine documented it for the same skin conditions and as an anthelmintic. Caribbean traditional medicine called it “consumption weed” and used it for respiratory conditions. South American medicine documented similar applications. When populations on three continents with no historical contact all identify the same plant for the same conditions, the plant is doing something observable. This convergence is the most powerful form of pre-clinical evidence — millennia of independent empirical observation.
The name “kucing galak” (fierce cat / wild cat) in Malay is a behavioural name — reflecting how the plant spreads aggressively into disturbed ground. The plant named for a wild cat grows wherever humans disturb the earth: roadsides, construction sites, cleared land, garden edges.
This growth pattern is pharmacologically significant: plants that grow in disturbed, sun-exposed, poor-soil environments develop higher concentrations of secondary metabolites (defence compounds) than plants in nutrient-rich, shaded environments. Kucing galak’s habitual growth in harsh conditions correlates with documented flavonoid and alkaloid content that provides its antimicrobial and anti-inflammatory activity. The plant that grows most aggressively in the hardest conditions is concentrating the compounds responsible for its traditional use.
Acalypha indica’s antifungal activity against Candida albicans is documented to be comparable to Clotrimazole — the standard pharmaceutical antifungal — in TLC and HPLC analysis verification. This finding is from peer-reviewed published research, not traditional claim.
Extracts from root, leaf, and stem demonstrated potent antifungal activity against Candida albicans, with Rf values matching standard clotrimazole in chromatographic comparison. Additional antimicrobial activity against Aspergillus niger and E. coli was documented. This is the mechanistic explanation for three continents independently using this plant for skin conditions — Candida is a primary cause of tropical skin infections, and the plant compounds demonstrate potency comparable to the pharmaceutical standard against it.
The Caribbean traditional name “consumption weed” — given because of traditional use for tuberculosis-related respiratory conditions — has been validated by laboratory research showing activity against Mycobacterium marinum, an organism in the same family as Mycobacterium tuberculosis.
Traditional knowledge pointed to mycobacterial infection as the target. Laboratory analysis found activity against a mycobacterial organism. The traditional name documented the observation; the laboratory identified the likely mechanism. This is not proof of tuberculosis treatment — the evidence is in vitro and the specific pathogen differs from M. tuberculosis — but it demonstrates that the traditional observation identified a real antimicrobial direction that laboratory research later confirmed.
Kucing galak is not widely discussed in Malaysian herbal medicine despite being documented in India (Ayurveda and Siddha), Indonesia, the Philippines, China, and multiple other Asian traditions — as well as African and South American medicine. The Malaysian name “kucing galak” is applied to a plant that Malaysian traditional medicine underutilises relative to its wider documentation.
The plant grows freely across Malaysia. The Orang Asli pharmacopoeia and traditional Malay medicine document it, but it receives far less attention than less-researched herbs. The pharmacological research base — antimicrobial, anti-inflammatory, anthelmintic, hepatoprotective — is more developed than the Malaysian public discussion of this herb reflects. The backyard weed most Malaysians have growing beside their drain or fence has a research profile most people have never heard of.
One Weed, Three Continents, Many Names
“Fierce cat” or “wild cat” for its aggressive spreading growth. Also called rumput lis-lis (striped grass) for the leaf vein pattern. Traditional Malay medicine uses it for skin conditions, wounds, and respiratory complaints.
One of the most documented Ayurvedic and Siddha herbs for skin conditions and respiratory applications. “Indian copperleaf” and “Indian mercury” in English. Documented across classical Ayurvedic texts for external skin applications and internal respiratory use at appropriate doses.
Used in Chinese folk medicine for similar skin and wound applications. The Chinese name acknowledges its pan-Asian distribution and traditional utility.
Named for its traditional use for tuberculosis-related respiratory conditions (“consumption” was the historical name for TB). The antimicrobial activity against mycobacterial organisms documented in laboratory research provides retrospective validation of this traditional name.
Used across West African traditional medicine for skin conditions and as an anthelmintic. The trans-oceanic occurrence of Acalypha indica across Africa, Asia, and South America reflects ancient trade routes and/or natural seed dispersal, with traditional uses converging independently.
Annual herb, 20–80cm high. Grows in disturbed soil, roadsides, waste places throughout tropical regions globally. Euphorbiaceae family. Identified by copper-coloured juvenile leaves, serrated leaf margins, and small flowers on long catkin-like spikes — the “cat’s tail” appearance that gives it an alternative English name.
What Kucing Galak Actually Contains
Acalyphine
The primary alkaloid identified specifically in Acalypha indica. Contributes to the bronchial and expectorant properties documented in traditional respiratory applications. Alkaloid fraction also contributes to antimicrobial activity and potential anticonvulsant effects noted in pharmacological studies. The acalyphine content varies between plant parts — leaves and roots have higher concentrations than stems.
Cyanogenic Glycosides
Present and requiring acknowledgment. These compounds can hydrolyse to release hydrogen cyanide under certain conditions. At the concentrations in Acalypha indica and at traditional usage doses, no documented mass poisoning events have occurred. Relevant for caution against large-quantity raw leaf consumption. Traditional preparation methods — cooking, small-dose decoction — reduce this risk. Topical use is not affected. Documented and acknowledged here; not a reason to avoid traditional use at appropriate doses, but a reason to understand the plant correctly.
Nicotiflorin, Clitorin, Mauritianin, Biorobin
Four documented kaempferol glycoside derivatives unique to Acalypha species: nicotiflorin (kaempferol-3-rutinoside), clitorin, mauritianin, and biorobin. Anti-inflammatory, antioxidant, and antimicrobial activity documented for the kaempferol glycoside class. These flavonoid glycosides are water-soluble — fully extractable in aqueous (tea/decoction) preparations, explaining the efficacy of traditional water-based preparations.
Phytol
A diterpene constituent of chlorophyll with documented NF-kB pathway suppression — the same anti-inflammatory mechanism documented across multiple herbs in this collection. Phytol suppresses pro-inflammatory cytokines (TNF-alpha, IL-1beta) and leukocyte migration. This provides the mechanistic basis for documented anti-inflammatory activity in carrageenan models.
Wound-Healing and Antimicrobial Fraction
Tannin fraction provides astringent wound-healing activity — precipitating surface proteins, forming a protective layer over wounds, and inhibiting the bacterial growth that causes wound infection. Saponins contribute additional antimicrobial and anti-inflammatory activity. The combination of tannins and kaempferol glycosides in topical application explains the traditional wound and skin application across three continents.
Expectorant and Antimicrobial Fraction
Volatile oil fraction contributes expectorant activity (facilitating mucus clearance from the respiratory tract) and direct antimicrobial activity. The documented activity against E. coli, S. aureus, Pseudomonas aeruginosa, and Salmonella typhi from the volatile and alkaloid fractions explains both the wound antimicrobial and respiratory antimicrobial traditional applications.
Three Research Areas
Comparable to Clotrimazole Against Candida — The Mechanism Behind Three Continents
Published research confirms significant antimicrobial activity from Acalypha indica extracts against a clinically relevant panel of pathogens. The antifungal finding is the most striking: root, leaf, and stem extracts demonstrated activity against Candida albicans with Rf values matching the standard pharmaceutical antifungal clotrimazole in chromatographic comparison. Activity against Aspergillus niger (a common cause of wound and skin infections in tropical climates) was also documented. Antibacterial activity has been confirmed against E. coli, Staphylococcus aureus, Pseudomonas aeruginosa, Salmonella typhi, Shigella flexneri, and Klebsiella pneumoniae.
This broad-spectrum antimicrobial profile — antifungal and antibacterial across multiple pathogen classes — provides the most convincing pharmacological explanation for why three independent traditional medicine systems converged on this plant for skin conditions and wound healing. Candida and Staphylococcus are the two most common causes of skin infections and wound contamination in tropical climates. A plant with documented comparable-to-clotrimazole activity against Candida and documented activity against Staphylococcus explains the empirical convergence across continents.
The mechanism is compound-level: alkaloids (including acalyphine) disrupt microbial cell membrane integrity; tannins precipitate surface proteins on pathogen cell walls; kaempferol glycosides inhibit microbial enzyme activity; volatile oil compounds penetrate and disrupt cell membranes. Multiple independent antimicrobial mechanisms from different compound classes working simultaneously.
Antifungal vs Candida albicans: Rf value matching clotrimazole documented. Antimicrobial vs E. coli, S. aureus, Aspergillus niger: documented. Antibacterial vs P. aeruginosa, S. typhi, Shigella flexneri, K. pneumoniae: documented. Mechanism: alkaloid membrane disruption, tannin protein precipitation, kaempferol glycoside enzyme inhibition, volatile oil membrane disruption.
NF-kB Suppression, Carrageenan Model Validation, and the Topical Wound Evidence
Published pharmacological studies using standard pharmaceutical test protocols document significant anti-inflammatory activity from Acalypha indica extracts. A study using oral ethanolic extract at 200 and 400 mg/kg demonstrated significant analgesic activity in two independent pain models, significant anti-inflammatory effect against carrageenan-induced inflammation, significant anti-inflammatory effect against adjuvant-induced polyarthritis, and antipyretic activity against yeast-induced fever. These are the same test protocols used in pharmaceutical drug evaluation.
The mechanism is primarily phytol-mediated NF-kB pathway suppression — reducing TNF-alpha, IL-1beta, and leukocyte migration. The tannin fraction contributes astringent wound-healing activity topically. The combination of anti-inflammatory (reducing the inflammatory response at the wound site) and antimicrobial (reducing the bacterial load causing infection) activity explains the traditional wound healing applications across cultures.
The hepatoprotective application documented in animal studies (significant protection against thioacetamide-induced liver toxicity) adds a further dimension to the anti-inflammatory profile — consistent with NF-kB pathway anti-inflammatory mechanisms reducing hepatic inflammation. Human clinical evidence for this application does not yet exist.
Anti-inflammatory: significant carrageenan-induced and adjuvant-induced inflammation reduction at 200 and 400 mg/kg. Analgesic: two independent pain models, significant reduction. Antipyretic: yeast-induced fever model. Mechanism: phytol NF-kB suppression, TNF-alpha and IL-1beta reduction. Hepatoprotective: significant protection vs thioacetamide toxicity in animal studies.
Expectorant Mechanism and Mycobacterial Activity — How Traditional Knowledge Identified the Right Target
The traditional respiratory applications of Acalypha indica — bronchitis, asthma, pneumonia, and “consumption” (tuberculosis) — are documented across Asian, Caribbean, and African traditional medicine. The leaf juice at small doses has documented expectorant properties (facilitating mucus clearance through bronchial smooth muscle effects of the alkaloid and volatile oil fraction). For acute respiratory infections, the antimicrobial activity provides additional mechanism.
The “consumption weed” name from Jamaican traditional medicine, given for TB-related respiratory conditions, has been partly validated by research showing activity against Mycobacterium marinum NAT — an enzyme in the same mycobacterial family as Mycobacterium tuberculosis. This is not evidence of tuberculosis treatment — M. marinum is not M. tuberculosis — but it demonstrates that the traditional application identified a real antimycobacterial direction in the plant’s pharmacology.
The honest assessment: the expectorant application for acute bronchitis and respiratory congestion has a documented mechanistic basis and is the most plausible internal respiratory application. The asthma application requires more evidence. The TB/consumption application is documented as a direction but not established as a clinical treatment. Human clinical trials for respiratory applications are absent.
Expectorant properties: documented at small doses. Alkaloid and volatile oil fraction: bronchial smooth muscle effects. Antimicrobial activity: respiratory pathogen panel. Mycobacterium marinum activity: documented. TB (M. tuberculosis) clinical application: not established. Human clinical trials respiratory: absent. Traditional use: three continents, consistent respiratory documentation.
Five Kucing Galak Applications
Applications across multiple traditional medicine systems — assessed against the pharmacological evidence with the safety context included.
“Pound fresh kucing galak leaves into a paste and apply to wounds, skin infections, and scabies.”
The strongest-supported application and the safest in terms of delivery. The antimicrobial activity against Candida albicans (comparable to clotrimazole), Staphylococcus aureus, and other skin pathogens provides direct mechanistic support for traditional topical wound and skin infection use. Tannin astringent activity forms a protective barrier. NF-kB anti-inflammatory activity (phytol-mediated) reduces wound inflammation. Three parallel mechanisms working simultaneously for wound healing.
The safety profile for topical use is favourable. Cyanogenic glycoside concerns do not apply to external use. The traditional practice of applying pounded fresh leaves or expressed juice to wounds and skin conditions across Asia and Africa reflects a sound pharmacological rationale. Apply to clean wounds, change twice daily. Discontinue if irritation develops.
“Drink kucing galak leaf decoction for coughs, bronchitis, and to clear the chest.”
The expectorant application has documented mechanistic basis through the alkaloid and volatile oil fraction’s bronchial effects. Small doses of leaf juice are documented as expectorant in Ayurvedic medicine. Traditional respiratory use across multiple Asian systems is consistent with this mechanism.
The internal safety note applies here: moderate dosing, prepared as a decoction (not large quantities of raw leaves), is the appropriate approach. Traditional Ayurvedic use specifies “in smaller doses it is expectorant” — the dose qualification is important. This is not a herb to consume in large quantities internally. For mild bronchitis and respiratory congestion as a supportive measure: a moderate decoction of a small number of leaves has pharmacological rationale. For severe respiratory infections: medical assessment is appropriate.
“Kucing galak tea has diuretic properties and can support kidney function.”
Acalypha indica is classified as a diuretic in Ayurvedic, Siddha, and Malay traditional medicine. The kaempferol glycoside fraction contributes diuretic activity (kaempferol derivatives are documented mild diuretics in multiple plant sources). The mechanism is less characterised than for misai kucing or pecah beling, which have more specific diuretic research.
For general mild diuretic support, the traditional classification is plausible. For specific kidney conditions, the evidence base for misai kucing and pecah beling is significantly more developed and would be the more appropriate choice. Kucing galak’s diuretic application is real but not its most evidence-supported use.
“Kucing galak root decoction expels intestinal worms and parasites.”
Anthelmintic (anti-parasitic) use is documented across African, Asian, and South American traditional medicine for Acalypha indica. Published in vitro anthelmintic activity studies confirm activity against intestinal parasites. The mechanism is attributed to the alkaloid fraction and saponins — compounds with documented anthelmintic activity in multiple plant families.
The anthelmintic application has mechanistic plausibility and traditional cross-continental documentation. It does not have large-scale human clinical evidence. For confirmed intestinal parasite infection: medical treatment is appropriate. As a traditional preventive measure at moderate doses alongside medical care: the pharmacological direction is documented.
“Kucing galak can be used for general inflammation and pain.”
The anti-inflammatory and analgesic applications are supported by published studies using standard pharmaceutical test protocols. Significant anti-inflammatory activity in carrageenan-induced and adjuvant-induced models. Significant analgesic activity in two independent pain models. Antipyretic activity in fever model. All documented at 200 and 400 mg/kg doses.
The mechanism is phytol-mediated NF-kB suppression — the same molecular pathway documented across multiple herbs in this collection. For topical anti-inflammatory application (applying pounded leaves to inflamed skin or joints), this is the most directly applicable evidence. For internal anti-inflammatory use, the moderate dosing principle applies.
Kucing Galak — The Fierce Cat That Malaysia Has Not Tamed Into Its Herb Library
Kucing galak grows everywhere in Malaysia — roadsides, drains, garden edges, construction sites, and disturbed ground throughout the peninsula. Most Malaysians encounter it daily without recognition. The Orang Asli pharmacopoeia documents it. Traditional Malay medicine uses it for skin conditions and respiratory complaints. And yet it receives far less attention in Malaysian herbal medicine discussion than its pharmacological research base — and its pan-continental traditional documentation — warrants.
India has developed the most extensive research and commercial use of this plant (as kuppaimeni) for external skin applications. Indonesian Jamu medicine documents it. The Philippines, China, and West Africa all include it in traditional pharmacopoeia. Malaysia has the plant growing in abundance and the traditional knowledge to use it — but has not yet systematically elevated it the way its Asian neighbours have.
The most appropriate Malaysian application, and the most evidence-supported globally, is topical: wound healing, skin infections, and antimicrobial compresses. The plant growing beside the drain at the edge of your garden may be the most accessible topical antimicrobial in Malaysian traditional medicine — with antifungal activity documented comparable to pharmaceutical standards.
Four Claims. Four Verdicts.
“Kucing galak is completely safe — it is just a weed that grows everywhere.”
Kucing galak has centuries of traditional use without documented mass adverse events at traditional doses. For topical use: safe profile well-documented. For moderate-dose internal use in traditional preparations: consistent historical record. However: it contains cyanogenic glycosides, and large-quantity consumption of raw leaves is not recommended. “Just a weed” framing dismisses compounds that require appropriate respect. Understanding the plant correctly allows safe traditional use; ignoring the compound profile is not the same as safety.
“Kucing galak cures tuberculosis and serious respiratory infections — drink lots of the tea.”
The mycobacterial activity documented is against Mycobacterium marinum, not M. tuberculosis. The activity is in vitro. Human clinical evidence for tuberculosis does not exist. More importantly: tuberculosis requires extended pharmaceutical antibiotic treatment; delaying this for herbal tea can allow progressive, potentially fatal lung damage. The “consumption weed” name reflects traditional observation of a real antimicrobial direction; it does not establish kucing galak as a tuberculosis treatment. For serious respiratory infection: medical assessment and appropriate treatment. For mild respiratory support as a complement: moderate dosing, not large quantity consumption.
“The only use for kucing galak is traditional medicine — no real science supports it.”
Published research in peer-reviewed journals documents: antifungal activity against Candida with Rf values matching clotrimazole; antibacterial activity against E. coli, S. aureus, Pseudomonas, Salmonella, Shigella, Klebsiella; anti-inflammatory activity using standard carrageenan and adjuvant protocols; analgesic activity in two pain models; antipyretic activity; anthelmintic activity in vitro; hepatoprotective activity in animal models; NF-kB pathway suppression mechanism; activity against mycobacterial organisms. This is a published pharmacological research base, not unsupported tradition.
“Kucing galak was only used in Malaysia — it is a local herb.”
Documented in Ayurveda and Siddha (India), Chinese folk medicine, Philippine traditional medicine, Indonesian medicine, West African traditional medicine (multiple countries), Jamaican traditional medicine (consumption weed), Brazilian and South American traditional medicine. Three continents. Independent empirical observation. Same applications. The plant is global, the knowledge is parallel, and the Malaysian name “kucing galak” is one name among many for a herb that humanity has been observing and using for millennia across cultures with no historical contact.
How to Use Kucing Galak
Topical applications are the most evidence-supported and safest. Internal use should follow the moderate-dosing traditional pattern, not large-quantity consumption.
Method: Wash fresh leaves. Pound or crush until juice is expressed. Apply to clean wound as compress. Cover lightly. Change twice daily.
Best for: Minor wounds, cuts, skin infections, scabies, skin fungal conditions.
Safety: Favourable for topical use. Discontinue if irritation or allergic reaction develops. Do not apply to deep wounds without medical assessment.
Method: Blend fresh leaves with minimal water. Strain. Apply juice to affected skin area with clean cloth.
Best for: Skin infections, fungal conditions, antimicrobial compress.
Note: Expressed juice has higher concentration than poultice. Test on small area first for skin sensitivity.
Method: 5–8 fresh leaves (small quantity) simmered in 2 cups water for 10–15 minutes. Strain. Drink 1 cup. Maximum 1 cup daily for short-term use.
Appropriate for: Mild respiratory congestion support, expectorant use.
Not appropriate for: Large quantities, extended daily use, or as a primary treatment for serious conditions. Follow traditional moderate-dosing practice.
Method: Young leaves boiled and eaten as a vegetable, in the tradition documented across West Africa and parts of Asia. Cooking deactivates the enzyme responsible for cyanogenic glycoside hydrolysis.
Note: This is the traditional food safety approach for plants containing cyanogenic glycosides — cooking is the standard method for reducing this compound class across traditional cuisines (same principle as cassava preparation).
Human clinical trial gap: The research base for kucing galak is primarily in vitro and animal studies. No human clinical trials for any application have been published. The pharmacological directions are well-documented and mechanistically sound; the clinical evidence in humans is absent. This is a plant where the traditional record across three continents is the most compelling evidence, supported by a consistent laboratory pharmacological direction.
The cyanogenic glycoside reality: This is documented and acknowledged. For topical use: irrelevant. For culinary use (cooked leaves): traditional food safety practice (cooking) addresses it. For internal decoction at moderate traditional doses: centuries of use without mass adverse events is the safety record. For large-quantity raw leaf consumption: not recommended. Understand the plant; use it appropriately.
Not for serious conditions as a primary treatment: TB, serious wound infections, severe asthma, and parasitic infections all warrant medical assessment and treatment. Kucing galak may be a pharmacologically rational complement for mild conditions and topical applications; it is not a replacement for medical care in serious illness.
References & Sources ↓
- Antifungal activity vs Candida albicans, Aspergillus niger: Rf value matching clotrimazole documented. TLC and HPLC analysis. International Journal of Pharmaceutical Sciences.
- Antibacterial activity vs E. coli, S. aureus, P. aeruginosa, S. typhi, Shigella flexneri, K. pneumoniae: Multiple published studies.
- Anti-inflammatory: carrageenan-induced and adjuvant-induced models, significant activity at 200 and 400 mg/kg. Journal of Ethnopharmacology.
- Analgesic: two independent pain models. Antipyretic: yeast-induced fever. Published pharmacological studies.
- Phytol NF-kB suppression mechanism: pro-inflammatory cytokine (TNF-alpha, IL-1beta) reduction. MDPI Molecules.
- Cyanogenic glycosides: documented presence in Acalypha indica. Major phytochemicals: acalyphine, cyanogenic glycoside, inositol, resin, volatile oils. Euphorbiaceae family context.
- Kaempferol derivatives: nicotiflorin (kaempferol-3-rutinoside), clitorin, mauritianin, biorobin isolated and identified.
- Hepatoprotective activity: significant protection against thioacetamide-induced toxicity. Animal studies.
- Anthelmintic activity: in vitro studies. Traditional documentation: India (Ayurveda/Siddha), Malaysia, Indonesia, Philippines, China, West Africa, Caribbean, South America.
- Mycobacterial activity: Mycobacterium marinum NAT inhibition. Caribbean traditional name “consumption weed” for TB respiratory conditions.
- COVID-19 research direction (2025): molecular docking studies identifying compounds with potential SARS-CoV-2 inhibitory activity. Early-stage research direction only.